Patents by Inventor Ming Foong Chai

Ming Foong Chai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
    Publication number: 20230325487
    Abstract: The present invention relates to production of therapeutic potential WJ-MSCs for clinical purposes. The WJ-MSCs cultured in optimal culture conditions for production of clinical grade WJ-MSCs wherein 4 different culture media which are Media A, Media B, Media C and Media D used to produce 4 types of WJ-MSCs with different therapeutic potential. The WJ-MSCs harvested from Media A has therapeutic potential related to immune, wound healing and cell migration and the WJ-MSCs harvested from Media B has therapeutic potential related to localization, cell proliferation and cell migration. Meanwhile, the WJ-MSCs harvested from Media C has therapeutic potential related to organ development and osteogenesis and the WJ-MSCs harvested from Media D has therapeutic potential related to tissue development, cell signaling and localization.
    Type: Application
    Filed: June 9, 2023
    Publication date: October 12, 2023
    Applicant: CRYOCORD SDN BHD
    Inventors: Ming Foong CHAI, Zhi Xin LEE, Vijayendran GOVINDASAMY, Soon Keng CHEONG, Khong Lek THEN
  • PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
    Publication number: 20200392454
    Abstract: The present invention relates to production of therapeutic potential WJ-MSCs for clinical purposes. The WJ-MSCs cultured in optimal culture conditions for production of clinical grade WJ-MSCs wherein 4 different culture media which are Media A, Media B, Media C and Media D used to produce 4 types of WJ-MSCs with different therapeutic potential. The WJ-MSCs harvested from Media A has therapeutic potential related to immune, wound healing and cell migration and the WJ-MSCs harvested from Media B has therapeutic potential related to localization, cell proliferation and cell migration. Meanwhile, the WJ-MSCs harvested from Media C has therapeutic potential related to organ development and osteogenesis and the WJ-MSCs harvested from Media D has therapeutic potential related to tissue development, cell signaling and localization.
    Type: Application
    Filed: October 15, 2019
    Publication date: December 17, 2020
    Inventors: Ming Foong Chai, Zhi Xin Lee, Vijayendran Govindasamy, Soon Keng Cheong, Khong Lek Then